Literature DB >> 7555500

Mortality and morbidity associated with body weight in people with IDDM. The WHO Multinational Study of Vascular Disease in Diabetes.

N Chaturvedi1, L K Stevens, J H Fuller.   

Abstract

OBJECTIVE: Strict glycemic control in people with insulin-dependent diabetes mellitus (IDDM) reduces the risk of microvascular complications, but improvements in control are also associated with weight gain. Fears about the mortality risks of obesity may limit the acceptability of tight control. Therefore, we examined morbidity and mortality risks associated with body weight in people with IDDM. RESEARCH DESIGN AND METHODS: This was a cohort study of 644 men and 576 women with IDDM from nine centers worldwide. Baseline examinations were performed in 1975-1977, and mortality follow-up continued until 1988.
RESULTS: Body weight was positively associated with blood pressure and, in men, with cholesterol. Fasting blood glucose was higher in the most obese groups in women only. There were 204 deaths among the men and 148 among the women. There was a reverse J-shaped relationship between body weight and all-cause mortality, with the highest mortality rates occurring in the leanest body mass index (BMI) category. The age-, duration-, and center-adjusted mortality rate ratio (95% confidence interval) comparing BMI category < 20 kg/m2 with BMI category > or = 22 and < 24 kg/m2 was 2.64 (1.59-4.38) in men and 1.54 (0.77-3.06) in women. Additional adjustment for smoking, blood pressure, glucose, cholesterol, and proteinuria did not qualitatively alter these findings.
CONCLUSIONS: We conclude that except in very lean people with IDDM, body weight is not significantly associated with mortality. Thus, efforts to improve glycemic control should not be restricted by concerns about the effects of weight gain on mortality.

Entities:  

Mesh:

Year:  1995        PMID: 7555500     DOI: 10.2337/diacare.18.6.761

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

1.  Tuning in to the ‘right’ calcium channel regulation in experimental models of diabetes.

Authors:  M Sturek
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 2.  Costs of insulin-dependent diabetes mellitus.

Authors:  T T Simell; H Sintonen; J Hahl; O G Simell
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

3.  Phosphatidylinositol 3-kinase-δ up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes.

Authors:  J F Pinho; M A A Medeiros; L S A Capettini; B A Rezende; P P Campos; S P Andrade; S F Cortes; J S Cruz; V S Lemos
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Exercise-induced cardiac performance in autoimmune (type 1) diabetes is associated with a decrease in myocardial diacylglycerol.

Authors:  Rajprasad Loganathan; Lesya Novikova; Igor G Boulatnikov; Irina V Smirnova
Journal:  J Appl Physiol (1985)       Date:  2012-07-12

Review 5.  Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies.

Authors:  Francesco Zaccardi; Nafeesa N Dhalwani; Dimitris Papamargaritis; David R Webb; Gavin J Murphy; Melanie J Davies; Kamlesh Khunti
Journal:  Diabetologia       Date:  2016-11-25       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.